Product Wiki · Recalls · EU Safety Gate (RAPEX)

Kolczyki — recall SR/00015/26

EU Safety Gate (RAPEX) · Poland · 2026-01-09 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/00015/26
Date of alert
2026-01-09
Country / jurisdiction
Poland
Risk level
Serious risk
Risk type
Chemical
Product category
Jewellery
Product type
Earrings
🔴 Serious hazard — Reported risk: Produkt ma nadmierne stężenie kadmu (zmierzona wartość: 4% wagowo). Kadm jest szkodliwy dla zdrowia ludzkiego, ponieważ gromadzi się w organizmie, może uszkadzać nerki i kości oraz może powodować raka. Produkt nie spełnia wymogów rozporządzenia REACH ani ogólnego rozporządzenia o bezpieczeństwie produktów.
Action taken by the authority
Type of economic operator taking notified measure
Importer
Category of measure
Withdrawal of the product from the market
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Kolczyki

Risk Description (original English): The product has an excessive concentration of cadmium (measured value: 4% by weight). Cadmium is harmful to human health because it accumulates in the body, can damage the kidneys and bones, and may cause cancer.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10097224

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.